Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinomaYang Chen, Yu Zhou, Ran Ren, Yu Chen, Juan Lei, Yongsheng Li
8 July 2024
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroidsElias Burri, Joanna Mangana, Phil F Cheng, Alia Schneider, Achim Weber, Reinhard Dummer, Egle Ramelyte
5 July 2024
Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinationsJane E Willoughby, Lang Dou, Sabyasachi Bhattacharya, Heather Jackson, Laura Seestaller-Wehr, David Kilian, Laura Bover, Kui S Voo, Kerry L Cox, Tom Murray, Mel John, Hong Shi, Paul Bojczuk, Junping Jing, Heather NiedererSee the full list of authors
4 July 2024
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 TILs based on BRCA1/2 mutation status in epithelial ovarian cancersJunsik Park, Jung Chul Kim, Yong Jae Lee, Sunghoon Kim, Sang Wun Kim, Eui-Cheol Shin, Jung Yun Lee, Su-Hyung Park
4 July 2024
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterizationWilliam Becker, Purevdorj B Olkhanud, Noriko Seishima, Paloma A Moreno, Katherine C Goldfarbmuren, Hoyoung M Maeng, Jay A Berzofsky
1 July 2024
Fc–Fc interactions and immune inhibitory effects of IgG4: implications for anti-PD-1 immunotherapiesWeifeng Zhang, Xueling Chen, Xingxing Chen, Jirui Li, Hui Wang, Xiaomiao Yan, Han Zha, Xiaonan Ma, Chanyuan Zhao, Meng Su, Liangli Hong, Penghao Li, Yanyu Ling, Wenhui Zhao, Yu XiaSee the full list of authors
25 June 2024
Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort studyYu-Qi Wang, Wen-Jin Chen, Wang Zhou, Ke-Qin Dong, Li Zuo, Da Xu, Jia-Xin Chen, Wei-Jie Chen, Wen-Yan Li, Zi-Chang Liu, Zheng-Yu Jiang, Yi-Fan Tang, Yu-Xuan Qin, Lin-Hui Wang, Xiu-Wu PanSee the full list of authors
21 June 2024
Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanomaLianjun Zhao, Yu Ren, Guiying Zhang, Kelin Zheng, Jiayu Wang, Huizi Sha, Mengke Zhao, Rong Huang, Donglin Kang, Xinyu Su, Yirong Wu, Wangling Zhang, Ruihe Lai, Lin Li, Rui MeiSee the full list of authors
21 June 2024
Complex immune microenvironment of chordoma: a road map for future treatmentHua-Qing Niu, Bo-Yv Zheng, Ming-Xiang Zou, Bo-Wen Zheng
21 June 2024
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trialJiwei Huang, Yueming Wang, Fan Xu, Zaoyu Wang, Guangyu Wu, Wen Kong, NG Cheoklong, Thibault Tricard, Xiaorong Wu, Wei Zhai, Wei Zhang, Jiyang Zhang, Ding Zhang, Shuyin Chen, Yuqing LianSee the full list of authors
11 June 2024